.webp&w=384&q=75){kind=logo}
About Course
This accredited digital CME program integrates contemporary precision oncology workflows for RET-altered cancers, covering end-to-end biomarker testing, MDT coordination, and evidence-based use of selective RET inhibitors across non–small cell lung cancer (NSCLC) and thyroid cancers, with embedded case studies and practical pearls aligned to current guidelines and late-breaking data.
Course Expert
This CME/CPD is eligible for credit points. Doctors shall confirm with the respective state medical council for number of CME/CPD Credits as well as payment requirements. CME/CPD credits are offered at sole discretion of respective state medical councils.
